TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Thrive Earlier Detection Stock

Thrive Earlier Detection Stock

thrivedetect.comHealthcareFounded: 2019Funding to Date: $110MM

Thrive is the developer a blood-based test that is designed to be affordable and utilized as part of routine medical care to detect multiple types of cancer at earlier stages.

Learn more about Thrive Earlier Detection IPO
Register for Details

For more details on financing and valuation for Thrive Earlier Detection, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Thrive Earlier Detection.

Register Today

Team

Management Team

Kenneth Kinzler Ph.D
Co-Founder & Board Member
Christoph Lengauer Ph.D
Co-Founder, Board Member & Chief Innovation Officer
Isaac Ro
Chief Financial Officer
Bert Vogelstein MD
Co-Founder
Samantha Singer
Chief Operating Officer
Steven Kafka Ph.D
Executive Chairman

Board Members

Christoph Lengauer Ph.D
Steven Kafka Ph.D
Kenneth Kinzler Ph.D
Alexis Borisy
Third Rock Ventures
Michael Pellini MD
Section 32

Other companies like Thrive Earlier Detection in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Precision Neuroscience
Sector
Healthcare
 
 

News

FINSMES 07/29/2020
Thrive Earlier Detection Raises $257M in Series B Financing | FinSMEs
Thrive Earlier Detection Corp., a Cambridge, MA-based company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care, raised $257m in Series B financing
Business Wire 09/23/2019
Thrive Earlier Detection Announces Appointment of Seema Singh Bhan as Senior Vice President, Public Policy and External Affairs
Thrive Earlier Detection Corp., a company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care,
Business Wire 08/01/2019
Thrive Earlier Detection Announces Appointment of David J. Daly as Chief Executive Officer
Thrive Earlier Detection Corp., a company dedicated to extending and saving lives by incorporating earlier cancer detection into routine medical care,

Trending Companies

Frequently Asked Questions